Maria P. Ballesteros

Plaza Ramón Y Cajal S/n
Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Engineering of 3D printed personalized polypills for the treatment of the metabolic syndrome.

Engineering of 3D printed personalized polypills for the treatment of the metabolic syndrome.

Journal: International journal of pharmaceutics

Published: April 16, 2023

Guiding Clinical Prescription of Topical Extemporaneous Formulations of Sodium Cromoglycate Based on Pharmaceutical Performance.

Guiding Clinical Prescription of Topical Extemporaneous Formulations of Sodium Cromoglycate Based on Pharmaceutical Performance.

Journal: Pharmaceutics

Published: April 03, 2023

Drug Stability: ICH versus Accelerated Predictive Stability Studies.

Drug Stability: ICH versus Accelerated Predictive Stability Studies.

Journal: Pharmaceutics

Published: October 07, 2022

Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases.

Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases.

Journal: ACS infectious diseases

Published: August 19, 2020

Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms.

Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms.

Journal: Pharmaceutics

Published: March 21, 2020

Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

Journal: Annals of translational medicine

Published: December 22, 2017

Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.

Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.

Journal: Molecular pharmaceutics

Published: February 16, 2017

Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting.

Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting.

Journal: International journal of pharmaceutics

Published: February 03, 2017

Analgesic and anti-inflammatory controlled-released injectable microemulsion: Pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation.

Analgesic and anti-inflammatory controlled-released injectable microemulsion: Pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: September 16, 2016

A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.

A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.

Journal: International journal of pharmaceutics

Published: July 17, 2015

Anthropometric measures of central abdominal fat and discriminant capacity for metabolic syndrome in a Spanish population

Anthropometric measures of central abdominal fat and discriminant capacity for metabolic syndrome in a Spanish population

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis

Published: March 04, 2013

Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations.

Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations.

Journal: International journal of pharmaceutics

Published: January 02, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026